TFAM and cancer: Interestingly, persistent mtDNA stress in TFAM-deficient mouse melanoma cells contributes to chemotherapy drug resistance in vitro and in vivo, suggesting that suppression of mtDNA damage and release might be a potential target to prevent cancer chemoresistance [57].